Trial intelligence / Profile preview

Nebulized colistin in ventilator-associated pneumonia

IRCT20190616043906N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jan 2020
Modality
Peptides
Countries
1
01

Overview

Phase 3 trial of colistin in ventilator-associated pneumonia (VAP), sponsored by Tehran University of Medical Sciences. Started Jan 2020; status: completed.

02

Drugs

colistin
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on IRCT20190616043906N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190616043906N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call